Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Simple Partial”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableUnknownNCT03457961
What this trial is testing

Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong

Who this might be right for
Focal EpilepsyGeneralized EpilepsyPartial Seizures, Simple
Chinese University of Hong Kong 80
Large-scale testing (Phase 3)Ended earlyNCT02519439
What this trial is testing

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT00910247
What this trial is testing

Eslicarbazepine Acetate Monotherapy Long Term Study

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc. 274
Large-scale testing (Phase 3)Study completedNCT00292461
What this trial is testing

Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Who this might be right for
Epilepsy
Eisai Inc. 64
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Large-scale testing (Phase 3)Study completedNCT01749046
What this trial is testing

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Who this might be right for
EpilepsySimple Partial SeizuresComplex Partial Seizures+1 more
Valexfarm 224
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Post-approval studies (Phase 4)Ended earlyNCT00215215
What this trial is testing

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Who this might be right for
Epilepsies, Partial
Cyberonics, Inc. 360
Large-scale testing (Phase 3)Study completedNCT00740623
What this trial is testing

The Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 547
Large-scale testing (Phase 3)Study completedNCT00866775
What this trial is testing

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Who this might be right for
Epilepsy With Simple or Complex Partial Onset Seizures
Sumitomo Pharma America, Inc. 193